อ้างอิง ของ ยาลดความอ้วน

  1. ↑ National Institute for Health and Clinical Excellence. Clinical guideline 43: Obesity: The prevention, identification, assessment and management of overweight and obesity in adults and children. London, 2006.
  2. ↑ "WIN – Publication – Prescription Medications for the Treatment of Obesity". National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). National Institutes of Health. Archived from the original on 13 January 2009. สืบค้นเมื่อ 14 January 2009.
  3. 1 2 "www.fda.gov".
  4. ↑ "Anti-obesity drug no magic bullet". Canadian Broadcasting Corporation. 2 January 2007. สืบค้นเมื่อ 19 September 2008.
  5. ↑ "FDA Briefing Document NDA 21-888 Zimulti (rimonabant) Tablets, 20 mg Sanofi Aventis Advisory Committee" (PDF). Food and Drug Administration. 13 June 2007. Archived (PDF) from the original on 10 September 2008. สืบค้นเมื่อ 19 September 2008.
  6. ↑ "www.emea.europa.eu" (PDF).
  7. ↑ "Abbott Laboratories Voluntarily Withdraws Weight-loss Drug Sibutramine (Meridia) from the Canadian Market – Health Canada Information Update 2010-10-08".
  8. ↑ Snow V, Barry P, Fitterman N, Qaseem A, Weiss K (2005). "Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians". Ann. Intern. Med. 142 (7): 525–31. doi:10.7326/0003-4819-142-7-200504050-00011. PMID 15809464.CS1 maint: Multiple names: authors list (link)
  9. ↑ Cooke D, Bloom S (2006). "The obesity pipeline: current strategies in the development of anti-obesity drugs". Nature reviews. Drug discovery. 5 (11): 919–31. doi:10.1038/nrd2136. PMID 17080028.
  10. ↑ doi:10.7326/0003-4819-119-7_Part_2-199310011-00016
    This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand
  11. ↑ Parascandola J (November 1974). "Dinitrophenol and bioenergetics: an historical perspective". Mol. Cell. Biochem. 5 (1–2): 69–77. doi:10.1007/BF01874175. PMID 4610359.
  12. 1 2 Pool, Robert (2001). Fat: Fighting the Obesity Epidemic. Oxford, UK: Oxford University Press. ISBN 0-19-511853-7.
  13. ↑ Weintraub M (May 1992). "Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study". Clin. Pharmacol. Ther. 51 (5): 581–5. PMID 1445528.
  14. ↑ Kolata, Gina (2007). Rethinking thin: The new science of weight loss – and the myths and realities of dieting. Picador. ISBN 0-312-42785-9.
  15. ↑
  16. ↑ Aronne, L.J. (2011). "Emerging pharmacotherapy for obesity". Expert Opinion on Emerging Drugs. 16 (3): 587–96. doi:10.1517/14728214.2011.609168. PMID 21834735. Unknown parameter |coauthors= ignored (|author= suggested) (help)
  17. ↑ Obesity, Fitness & Wellness Week (14 August 2004). "Legal Issues; Court dismisses claims against anti-obesity medication". สืบค้นเมื่อ 9 April 2012.
  18. ↑ Rockoff, Jonathan D.; Dooren, Jennifer Corbett (8 October 2010). "Abbott Pulls Diet Drug Meridia Off US Shelves". The Wall Street Journal. Archived from the original on 11 October 2010. สืบค้นเมื่อ 8 October 2010.
  19. ↑ "Top obesity drug sibutramine being suspended". BBC News. 22 January 2010. Archived from the original on 25 January 2010. สืบค้นเมื่อ 22 January 2010.
  20. ↑ Sibutramin-Vertrieb in der Europäischen Union ausgesetzt . Abbott Laboratories in Germany. Press Release 2010-01-21. Retrieved 2010-01-27 (เยอรมัน)
  21. ↑ "Sibutramine (brand name Reductil) Information – Australia". Abbott Laboratories. 2010. Archived from the original on 14 October 2010. สืบค้นเมื่อ 8 October 2010.
  22. ↑ Health Canada Endorsed Important Safety Information on MERIDIA (Sibutramine Hydrochloride Monohydrate) : Subject: Voluntary withdrawal of Meridia (sibutramine) capsules from the Canadian market.
  23. ↑ "De-registration of pharmaceutical products containing sibutramine" (Press release). info.gov in Hong Kong. 2 November 2010. สืบค้นเมื่อ 8 November 2010.
  24. ↑ "Top 10 Diet Pills That Work in 2014". TENMANIA. 2014. สืบค้นเมื่อ April 15, 2014.
  25. ↑ http://www.nice.org.uk/nicemedia/live/11000/30364/30364.pdf
  26. 1 2 3 Akbas F, Gasteyger C, Sjödin A, Astrup A, Larsen TM (January 2009). "A critical review of the cannabinoid receptor as a drug target for obesity management". Obes Rev. 10 (1): 58–67. doi:10.1111/j.1467-789X.2008.00520.x. PMID 18721231.CS1 maint: Multiple names: authors list (link)
  27. ↑ George A. Bray and Frank L. Greenway (1999). "Current and Potential Drugs for Treatment of Obesity: Table 19: Clinical trials with metformin for the treatment of obese diabetics". Endocrine Reviews. 20 (6): 805–87. doi:10.1210/er.20.6.805. PMID 10605627. สืบค้นเมื่อ 7 August 2006.
  28. ↑ http://teacherlink.ed.usu.edu/nmsmithpages/Personal/Diabetes%20Care%20Reference%20Materials/Diabetes%20Medications-%20Metformin.pdf
  29. ↑ de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O (2007). "Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects". Ann. Nutr. Metab. 51 (2): 134–8. doi:10.1159/000103273. PMID 17536190.CS1 maint: Multiple names: authors list (link)
  30. ↑ Abenhaim L; Moride Y; Brenot F; และคณะ (August 1996). "Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group". N. Engl. J. Med. 335 (9): 609–16. doi:10.1056/NEJM199608293350901. PMID 8692238. Unknown parameter |author-separator= ignored (help)
  31. ↑ Alfred P. Fishman, MD (1999). "Aminorex to Fen/Phen: An Epidemic Foretold". Circulation. 99 (1): 156–161. doi:10.1161/01.CIR.99.1.156. PMID 9884392. สืบค้นเมื่อ 24 July 2006.
  32. ↑ U.S. Food and Drug Administration: The Facts About Weight Loss Products and Programs
  33. ↑ "Prepared Statement of the Federal Trade Commission on the Marketing of Dietary Supplements" (Press release). Committee on Governmental Affairs, United States Senate. 8 October 2002. Archived from the original on 25 August 2006. สืบค้นเมื่อ 7 August 2006.
  34. ↑ Martin M, Schlabach G, Shibinski K (1998). "The Use of Nonprescription Weight Loss Products Among Female Basketball, Softball, and Volleyball Athletes from NCAA Division I Institutions: Issues and Concerns". J Athl Train. 33 (1): 41–44. PMC 1320374. PMID 16558483.CS1 maint: Multiple names: authors list (link)
  35. ↑ George A. Bray and Frank L. Greenway (1999). "Current and Potential Drugs for Treatment of Obesity: Postabsorptive modifiers of nutrient metabolism". Endocrine Reviews. 20 (6): 805–87. doi:10.1210/er.20.6.805. PMID 10605627.
  36. ↑ Salynn Boyles (2012-07-17). "FDA approves diet drug Qsymia : agency warns of increased risk for oral birth defects". WebMD., citing "FDA approves weight-management drug Qsymia" (Press release). U.S. Food and Drug Administration. 2012-07-17.
  37. ↑ Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E (April 2007). "2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]". CMAJ. 176 (8): S1–13. doi:10.1503/cmaj.061409. PMC 1839777. PMID 17420481.CS1 maint: Multiple names: authors list (link)
  38. 1 2 Onakpoya IJ, Posadzki PP, Watson LK, Davies LA, Ernst E (March 2012). "The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials". Eur J Nutr (Systematic review). 51 (2): 127–34. doi:10.1007/s00394-011-0253-9. PMID 21990002.CS1 maint: Multiple names: authors list (link)
  39. 1 2 3 Shekelle PG, Hardy ML, Morton SC; และคณะ (March 2003). "Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis". JAMA. 289 (12): 1537–45. doi:10.1001/jama.289.12.1537. PMID 12672771.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
  40. ↑ Bachorik, Lawrence. "FDA Announces Withdrawal Fenfluramine and Dexfenfluramine (Fen-Phen)". U.S. Food and Drug Administration. FDA. สืบค้นเมื่อ 2014-01-27.
  41. ↑ , Launceston, Tasmania, Australia, Examiner, Friday, January 21, 1938, p 14, which states in postscript “However, the sex which for many years injured its health by tight lacing is not likely to be deterred from slimming by such considerations, The dictates of fashion will be paramount." Sir Arthur was particularly concerned with the neurological side effects of the then popular practice of dosing with thyroid extract to lose weight and, also, use of the then much vaunted weight loss drug dinitrophenol, which his report found killed as many patients as it reduced in girth, as well as, the compromise of the malnourished’s immune system and their consequent, often, inability to resist infectious diseases like the then endemic tuberculosis (archaic “epidemics of consumption”).
  42. ↑ See, also, , Sidney Morning Herald, Nov. 17, 1937, p 10.
  43. ↑ Johnson, Kimball. "Alli: A Weight Loss Drug". WebMD. WebMD. สืบค้นเมื่อ 2014-01-27.
  44. ↑ "acarbose - oral, Precose". MedicineNet. MedicineNet. สืบค้นเมื่อ 2014-01-27.
  45. ↑ Peptimmune homepage
  46. ↑ McBride, Ryan. "Genzyme-Spinout Peptimmune Files for Chapter 7 Liquidation". Xconomy Boston. สืบค้นเมื่อ 5 September 2011.
  47. ↑ Leonardsson G; Steel JH; Christian M; Pocock V; และคณะ (2004). "Nuclear receptor corepressor RIP140 regulates fat accumulation". Proc. Natl. Acad. Sci. U.S.A. 101 (22): 8437–42. doi:10.1073/pnas.0401013101. PMC 420412. PMID 15155905. Unknown parameter |author-separator= ignored (help)
  48. ↑ Nofsinger RR, Li P, Hong SH, Jonker JW, Barish GD, Ying H, Cheng SY, Leblanc M, Xu W, Pei L, Kang YJ, Nelson M, Downes M, Yu RT, Olefsky JM, Lee CH, Evans RM. (2008). "SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis". Proc. Natl. Acad. Sci. U.S.A. 105 (50): 20021–6. doi:10.1073/pnas.0811012105. PMC 2598729. PMID 19066220.CS1 maint: Multiple names: authors list (link)
  49. ↑ "Research Shows First-of-Its-Kind Hydrogel Decreases Obese Patients’ Desire for Food", press release by the American Association of Clinical Endocrinologists, 22 April 2010 text
  50. ↑ Mintchev MP, Deneva MG, Aminkov BI, Fattouche M, Yadid-Pecht O, Bray RC (1 February 2010). "Pilot study of temporary controllable gastric pseudobezoars for dynamic non-invasive gastric volume reduction". Physiol. Meas. 31 (2): 131–44. doi:10.1088/0967-3334/31/2/001. PMID 20009188.CS1 maint: Multiple names: authors list (link)

แหล่งที่มา

WikiPedia: ยาลดความอ้วน http://trove.nla.gov.au/ndp/del/article/52188122 http://www.cbc.ca/health/story/2007/01/02/rimonaba... http://hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/... http://www.hc-sc.gc.ca/ahc-asc/media/advisories-av... http://media.aace.com/press-release/research-shows... http://news.google.com/newspapers?nid=1301&dat=193... http://www.medicinenet.com/acarbose-oral/article.h... http://www.nature.com/nrd/journal/v5/n11/abs/nrd21... http://www.peptimmune.com http://bf4dv7zn3u.search.serialssolutions.com/?ctx...